By Deborah Davis, MS, MBA
Infection control is a vital concern in healthcare today, andintelligent and informed use of personal protective equipment is a criticalcomponent of your facility's infection control program. Medical gloves are partof PPE that are most frequently donned by healthcare professionals today.
When choosing a glove, the first consideration should be the barrierrequirement related to the procedure or task. Consider the level of exposurerisk prior to selecting a glove. Patient care activities that involve exposureto blood, body fluids, and other potentially infectious material and activitiesthat may stress the glove material, such as handling of instruments and sharpsand management of vascular lines, are examples of high-risk situations. Patientcare activities that require glove use for short periods of time and minimalexposure to blood or body fluids are considered low risk for exposure. Examplesof low risk situations are administering an intramuscular injection, routinesuctioning, caring for a newborn, emptying a urinal, and handling food.Individual usage patterns and length of time that the glove is worn may alsoaffect glove barrier effectiveness.
While price is certainly an important factor and comfortable fit, ease ofdonning, and grip need to be considered, barrier protection is the reason glovesare worn in the first place. So what should you look for when selecting medicalgloves? Medical gloves are regulated by the Food and Drug Administration (FDA)and must meet certain performance criteria. Many other optional tests can giveadditional information about how the gloves will perform.
Additionally, gloves labeled as "powder-free" are required by theFDA to have 2 milligrams or less of total particulate per glove, and the lowestallowed protein level claim is "less than or equal to 50 micrograms perglove."
Suppliers know what test methods were used in generating these data. TheAmerican Society for Testing and Materials (ASTM) has standardized methods totest for many of these parameters. Using these standardized methods helps assurethe technical validity of the testing and provides consistency when makingcomparisons among different products.
Understanding the tests and standards that are used to measure theperformance of medical gloves and the significance of the results will help youto choose products that provide the best barrier protection and performance forboth healthcare workers and their patients.
Deborah Davis, MS, MBA, is technical director for the Gloves BusinessUnit of Allegiance Healthcare Corporation. Her primary responsibilities includedriving clinical research initiatives, coordinating various aspects of productdevelopment between the marketing, regulatory, manufacturing, research anddevelopment organizations; and publication and presentation of technicalinformation for customers and field sales personnel. Davis is currently adoctoral student at the University of Wisconsin, Milwaukee.
Ask the supplier for the following information when selecting medicalgloves:
Tensile Stress (modulus)
For a complete list of references click here
The Role of Environmental Hygiene in Preventing Antimicrobial Resistance
March 19th 2024Uncover the pivotal role of environmental hygiene in thwarting antimicrobial resistance (AMR) for infection prevention teams. Learn how rigorous cleaning protocols and advanced technologies enhance patient safety and combat AMR.
COVID-19 Harmonization: Balancing Risks and Benefits of CDC's Latest Move
March 11th 2024The CDC's recent decision to align recommendations for respiratory viruses, particularly COVID-19, has garnered support from the public and infectious disease societies. However, as the Infectious Diseases Society of America (IDSA) lends its backing to the CDC's harmonization efforts, concerns persist regarding the implications of this shift, especially considering the Omicron variant's unique characteristics and the ongoing challenges posed by COVID-19's multi-system impacts.
Voices of Resilience: Q&A With the Editor of "Corona City: Voices From an Epicenter"
March 1st 2024Step into the diverse and poignant world of "Corona City: Voices From an Epicenter" with editor Lorraine Ash, MA. In this insightful Q&A, learn about the origins of this remarkable anthology, the challenges faced in capturing raw, unfiltered narratives of the COVID-19 pandemic, and the lasting impact of these stories on readers and communities alike.
Rare Disease Day 2024: Spotlight on Rare Infectious Diseases
February 29th 2024Rare Disease Day on February 29, 2024, shines a global light on the impact of rare diseases, including rare infectious diseases. With a focus on early diagnosis and treatment access, this day highlights the struggles of those with rare conditions.
COVID-19 Realities: Beyond a Respiratory Virus, Addressing Optimism in Pandemic Management
February 28th 2024A recent commentary by Dr. Amesh Adalja in MedPage Today challenges the perception of COVID-19 as solely a respiratory virus, highlighting its broader impact on the body. This analysis questions the notion that COVID-19 should be managed like common respiratory infections, urging a closer look at vaccine effectiveness, the rise of long COVID, and the need for enhanced measures to curb the virus's spread. Let's explore the complexities of COVID-19 management and the pressing realities faced by the US and the world.